Noto, A., De Vitis, C., Roscilli, G., Fattore, L., Malpicci, D., Marra, E., . . . Ciliberto, G. (2013). Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer. Impact Journals LLC.
Citação norma ChicagoNoto, Alessia, et al. Combination Therapy With Anti-ErbB3 Monoclonal Antibodies and EGFR TKIs Potently Inhibits Non-small Cell Lung Cancer. Impact Journals LLC, 2013.
Deismireacht MLANoto, Alessia, et al. Combination Therapy With Anti-ErbB3 Monoclonal Antibodies and EGFR TKIs Potently Inhibits Non-small Cell Lung Cancer. Impact Journals LLC, 2013.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.